The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Path to IND for Biologics Delivers Phase I Clinical Trial Material in as few as 8 months*
Fact Sheet
The pressure to file an IND makes accelerated Phase I safety testing a priority. With the Path to IND for biologics, Thermo Fisher Scientific can help deliver your large molecule drug substance for First-in-Human studies in as little as 9 months* from the start of transfection.
Now you can meet important milestones—such as filing for IND—or secure additional funding with all the confidence your project needs and, we can supply.
*Terms and Conditions: Titer levels provided are estimates based on third-party results and may vary depending on molecule type and other factors. Timelines from DNA to drug product and start of clinical trials for all Path to IND for biologics options may vary depending on molecule type and other factors and are estimates to be finalized after third-party cell line development dates are available. The 8-month timeline is based on US-based sites only and may incur additional risk.
